George Carrum, MD

Associate Professor
Department of Medicine,
Section of Hematology-Oncology,
Baylor College of Medicine
Director
Adult Outpatient Clinic
The Methodist Hospital

 

 


Contact Information:
gcarrum@bcm.edu
713-394-6250


Education:
B.A., St. Mary's University, San Antonio, Texas 
M.D., Baylor College of Medicine, Houston, Texas 
Hematology Fellow, Baylor College of Medicine, Houston, Texas 


Research Interests:
Dr. Carrum's current clinical interests include high dose chemotherapy and stem cell rescue for Multiple Myeloma, Amyloidosis, Lymphoma and Leukemia. He is interested in post-transplant immunotherapy for Multiple Myeloma and Sybmyeloablative Regimens with allogenic stem cell rescue for patients with malignant diseases.

Selected Publications:
Carrum G, Abernethy DR, Sadhukkanm, Wright EC. Minoxidil Analysis in Human Plasma using high performance liquid chromatography with electrochemical detection: Application to pharmocokinetic studies. J Chromatography, 38(1):127-35,1986.

Carrum G, Egan JM, Abernethy DR. Diltiazem treatment impairs hepatic drug oxidation: Studies of antipyrine. Clin Pharm Ther, 40(2):140-3,1986.

Abernethy DR, Egan JM, Dickinson TH, Carrum G. Substrate selective inhibition by Verapamil and Diltiazem: Differential disposition of antipyrine and theophylline in humans.  J Pharmacol Ther, 244(3):994-9,1988.

Carrum G, Moore DF, Hagemeister FB, Crow MK, Cabanillas F. Clinical features and outcome for patients 60 years and older with Hodgkin's disease. Proc Annu Meet Am Soc Clin Oncol, 13:A1324,1994.

Tongol J, Carrum G. Allogeneic bone marrow transplantation in a patient with mantle cell lymphoma. Proc Annu Meet Am Soc Clin Oncol, 14:a11,1995.

Al-Awami Y, Sears D, Carrum G, Udden M, Alter B, Conlon C. Pure Red Cell Aplasia Associated with Hepatitis C Infection. Am J Med Sci, 314(2):113-117,1997.

Yavorkovsky L, Carrum G, Bruce S, McCarthy P. Cutaneous Sarcoidosis in a Patient With Philadelphia-Positive Chronic Myelogenous Leukemia Treated With Interferon. Am J Hematol, 58(1):80-1, May 1998.

Nasta SD, Carrum G, Shahab I, Hanania NA, Udden MM. Regression of aplasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002 Feb;43(2):423-6.

Hsu B, May R, Carrum G, Krance R, Przepiorka. Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey. Bone Marrow Transplant. 2001 Nov;28(10):945-50.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.Hum Gene Ther. 2000 Jul 1;11(10):1465-75.

Roskrow MA, Rooney C, Heslop HE, Brenner MK, Krance RA, Gresik MV, McClain K, Aguilar LK, Grilley B, Rob E, Carrum G. Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 1998 May 20;9(8):1237-50.

 

CAGT Home | BCM Home | Privacy Notices

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified:August 15, 2006- SM)